Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
43
IPHA Quote, Financials, Valuation and Earnings
Last price:
$2.15
Seasonality move
:
-9.3%
Day range:
$2.14 - $2.20
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.75x
P/B ratio:
21.35x
Volume:
6.4K
Avg. volume:
27.3K
1-year change:
-19.92%
Market cap:
$196.3M
Revenue:
$13.7M
EPS (TTM):
-$0.45
Innate Pharma SA Number of Institutional Trades
Innate Pharma SA Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$30.1K
(Last 6 Months)
Current Institutional Ownership Percentage
0.14%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.5M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Innate Pharma SA Institutional Ownership
-
What Percentage Of IPHA Is Owned by Institutions?
0.14% of IPHA is owned by institutions.
-
How Many Institutions Own IPHA Shares?
Innate Pharma SA stock is owned by 11 institutional shareholders at this time.
-
Have Institutions Been Buying IPHA Stock?
Yes, institutions have bought 7.1K shares of IPHA in the last quarter.
-
Have Institutions Been Selling IPHA Stock?
Yes, institutions have sold 448.4K shares of IPHA over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
